
Volume
$20K
Txns
180
Traders
61
Fees
$0
Ends
Jun 30, 2025
This market will resolve to "Yes" if Trump nominates David Friedberg for Commissioner of Food and Drug Administration by June 30, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No". This market will resolve based on Trump's first nomination for this position - if Trump nominates another person to this position first, this market will immediately resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting may also be used.
Trades
| Age | Trader | Outcome | Shares | Value | |
|---|---|---|---|---|---|
| 1y | 3r3rsdfs | Yes / 0.1¢ | +350.00 | $0.35 | |
| 1y | Apsalar | Yes / 0.2¢ | +2,250.00 | $4.5 | |
| 1y | Geromi | Yes / 0.1¢ | +22.00 | $0.02 | |
| 1y | notebookled | Yes / 0.1¢ | +20.00 | $0.02 | |
| 1y | AIisTheNewWalkingDead | No / 99.8¢ | +2,642.00 | $2.64K | |
| 1y | cigarettes | No / 99.8¢ | +750.00 | $749 | |
| 1y | Apsalar | Yes / 0.2¢ | +750.00 | $1.5 | |
| 1y | cigarettes | No / 99.7¢ | +1,620.00 | $1.62K | |
| 1y | Evador | Yes / 0.3¢ | +1,410.00 | $4.23 | |
| 1y | daroghi | Yes / 0.3¢ | +210.00 | $0.63 | |
| 1y | Twizzler | Yes / 0.3¢ | +10.00 | $0.03 | |
| 1y | Evador | Yes / 0.3¢ | +3,900.00 | $11.7 | |
| 1y | PolyDump | Yes / 0.3¢ | +10.00 | $0.03 | |
| 1y | NoVis | Yes / 0.3¢ | +20.00 | $0.06 | |
| 1y | MMousse | No / 99.7¢ | +3,940.00 | $3.93K | |
| 1y | Evador | Yes / 0.3¢ | +50.00 | $0.15 | |
| 1y | IdiotDoomSpiral | Yes / 0.3¢ | -50.00 | $0.15 | |
| 1y | Evador | Yes / 0.3¢ | +40.00 | $0.12 | |
| 1y | Threek | Yes / 0.3¢ | -40.00 | $0.12 | |
| 1y | daroghi | Yes / 0.3¢ | +40.00 | $0.12 | |
| 1y | retelev | Yes / 0.3¢ | -40.00 | $0.12 | |
| 1y | wokerjoesleeper | No / 99.9¢ | +38.54 | $38.5 | |
| 1y | Apsalar | Yes / 0.1¢ | +38.54 | $0.04 | |
| 1y | Apsalar | Yes / 0.1¢ | +21.00 | $0.02 | |
| 1y | Apsalar | Yes / 0.1¢ | +22.12 | $0.02 |
1–25
FDA approves Daraxonrasib this year?
Yes 76%$0volume
FDA approves Sanofi's Subcutaneous Sarclisa?
Yes 85%$0volume
FDA approves Viatris' low-dose estrogen weekly patch?
Yes 85%$0volume
FDA approves Outlook Therapeutics' ONS-5010?
Yes 86%$0volume
FDA approves MannKind's Afrezza?
Yes 100%$0volume
FDA approves Merck's Welireg + Keytruda or Keytruda Qlex?
Yes 100%$0volume